Greenwich LifeSciences, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Greenwich LifeSciences, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$19.45M	-$16.01M	-$9.33M	-$8.04M	-$4.60M	-$1.86M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$19.36M	-$15.79M	-$8.89M	-$7.83M	-$4.57M	-$1.86M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-1.00	$-1.00	$0.00	$0.00	$-0.35	$-0.20
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-1.00	$-1.00	$0.00	–	–	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$6.18M	$4.09M	$6.99M	$13.47M	$27.20M	$28.66M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$6.18M	$4.09M	$6.99M	$13.48M	$27.22M	–
Everything the company owes — debt, unpaid bills, and other obligations.	$5.82M	$1.56M	$294406	$262905	$385172	–
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$353217	$2.53M	$6.70M	$13.21M	$26.83M	–

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$9.91M	-$7.27M	-$6.48M	-$6.20M	-$4.29M	-$1.15M